When Paul Hall was diagnosed with stage 4 lung cancer in October 2021, he said, “I’m not quitting.” ...

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients ...

Researchers from Touro University and Lovelace Biomedical are Developing an Innovative Treatment for Lung Cancer ...

Treatment resistance and relapse in the most common type of lung cancer can be traced to a protein called agrin, according to ...

Screening tests are critical in early detection because they can find cancer before symptoms appear, when treatment is more ...

A new study validates NRG1 gene fusions as a targetable driver of advanced NRG1 fusion-positive cancers, adding support for ...

DURHAM, N.C. (WNCN) — A Durham man with stage four lung cancer credits a Duke clinical trial for giving him his life back.

Moreover, the panelists emphasized that real-world evidence goes beyond clinical trial data. It involves continuous patient monitoring, proactive adverse effect management, and adapting protocols ...

Baptist Health-Fort Smith announced Friday the addition of technology aimed at transforming the diagnosis and treatment of ...

From new KRAS and HER2 inhibitors to home-administered immunotherapy, recent trials mark a turning point in how metastatic lung cancer is managed.

The programme aims to enhance access to targeted cancer therapies by identifying actionable genetic mutations in lung cancer patients ...

fast response sensor to detect lung cancer biomarkers, paving the way for the development of screening devices to spot the disease even before symptoms occur. ... Exposure to Air Pollution ...